Publications

27 Mar 2000
Conference Presentation

Biotechnology Industry Organization Paper

By: Michael Porter

Keywords: Biotechnology Industry

February 2000 (Revised October 2000)
Case

Kendle International Inc.

By: Dwight B. Crane, Paul W. Marshall and Indra Reinbergs

Candace Kendle and Christopher Bergen, the CEO and COO of Kendle International, Inc., are reviewing ways to finance the growth of their privately-owned company. Kendle is a contract research organization that conducts clinical drug trials for pharmaceutical and... View Details

Keywords: Acquisition; Financing and Loans; Venture Capital; Stock Options; Banks and Banking; Debt Securities; International Finance; Financial Strategy; Management Skills; Private Ownership; Initial Public Offering; Biotechnology Industry; Biotechnology Industry

December 1999 (Revised August 2001)
Case

Millennium Pharmaceuticals, Inc. (A)

By: Stefan H. Thomke and Ashok Nimgade

Focuses on Millennium's strategy to grow and revolutionize drug development through the use of new technologies such as genomics. Describes how Millennium Pharmaceuticals--a fast-growing biotechnology firm in Cambridge, MA--has used strategic alliances to finance the... View Details

Keywords: Cost Management; Financing and Loans; Medical Specialties; Retention; Growth and Development Strategy; Time Management; Product Development; Problems and Challenges; Alliances; Technology; Biotechnology Industry; Biotechnology Industry; Cambridge

November 1999
Case

Seminis Inc.

By: Ray A. Goldberg, Jonathan West, Carin-Isabel Knoop and David Benedict Pearcy

Seminis became the world leader in vegetable seeds through a series of acquisitions. This case describes the Seminis strategy toward capturing value, biotechnology, and international operations. View Details

Keywords: Business Earnings; Acquisition; Profit; Global Strategy; Corporate Strategy; Valuation; Value Creation; Biotechnology Industry

October 1999
Case

Agricultural Biotechnology Brief, 1999

By: Forest L. Reinhardt and Jennifer Burns

Keywords: Business and Government Relations; Environmental Sustainability; Biotechnology Industry; Biotechnology Industry

May 1999
Teaching Note

Elliot Lebowitz TN

By: Paul A. Gompers

Teaching Note for (9-297-094). View Details

Keywords: Biotechnology Industry

May 1999
Teaching Note

Genset Initial Public Offering (A) & (B) TN

By: Paul A. Gompers

Teaching Note for (9-297-096) and (9-297-097). View Details

Keywords: Biotechnology Industry; United States; France

May 1999
Teaching Note

Genset: 1989 TN

By: Paul A. Gompers

Teaching Note for (9-298-070). View Details

Keywords: Biotechnology Industry; France

October 1998 (Revised December 1999)
Case

Gene Research, the Mapping of Life and the Global Economy

By: Ray A. Goldberg and Juan Enriquez-Cabot

A new firm is being created to speed up the process of mapping humans, animals, and plants by combining gene technology with rapid gene identification to improve the health and well being of the human population and the productivity of crops and animals. How does one... View Details

Keywords: Information Technology; Organizational Structure; Technological Innovation; Business Processes; Health Care and Treatment; Performance Productivity; Welfare; Agribusiness; Genetics; Science-Based Business; Biotechnology Industry; Biotechnology Industry

September 1998
Case

Monsanto's March into Biotechnology (C)

By: Dorothy A. Leonard and Robert Irwin

Supplements the (A) and (B) cases. View Details

Keywords: Plant-Based Agribusiness; Science-Based Business; Biotechnology Industry

Article

The Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry

By: Josh Lerner and Robert P. Merges

Keywords: Information Technology; Alliances; Information; Biotechnology Industry

January 1998 (Revised September 2001)
Case

Genset: 1989

By: Paul A. Gompers and Amy Burroughs

Discusses the start-up strategy at Genset, a French biotech firm. Pascal Brandys, a venture capitalist, and Marc Vasseur, a leading French scientist, must decide how to proceed. Future real options are central to the strategy. View Details

Keywords: Strategy; Venture Capital; Business Startups; Biotechnology Industry; France

October 1997
Case

Roslin Institute, The

By: Ray A. Goldberg and Tom Clay

Dr. Ian Willmut and the Roslin Institute have developed a revolutionary new technology--cloning. Now they are faced with some tough choices concerning going forward. How should they balance commercialization opportunities with societal concerns? View Details

Keywords: Decision Choices and Conditions; Independent Innovation and Invention; Social Issues; Commercialization; Biotechnology Industry

September 1997 (Revised October 1997)
Case

Bayer AG (A)

By: John A. Quelch

Bayer's senior executives convene in Germany to consider submitting a $1 billion bid that would recover the Bayer brand name and trademark cross in North America, both of which were confiscated by the U.S. government after World War I. The group also sets out to assess... View Details

Keywords: Management Teams; Brands and Branding; War; Communication; Trademarks; Acquisition; Government and Politics; Biotechnology Industry; Biotechnology Industry; Germany; North America; United States

September 1997
Case

Bayer AG (B)

By: John A. Quelch

Bayer's senior executives detail the communications challenge program that resulted from the company's reacquisition of its brand name and trademark cross, which gave Bayer one name worldwide for the first time since World War I. View Details

Keywords: Globalized Firms and Management; War; Acquisition; Trademarks; Brands and Branding; Communication Strategy; Biotechnology Industry; Biotechnology Industry; Germany